Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Int Mater Rev. 2021 Jul 5;67(4):347–384. doi: 10.1080/09506608.2021.1946236

Figure 11.

Figure 11.

(a) Designed and printed scaffolds with various shapes of MgPSr-PCL30. (b) Schematic representation of the implantation of cylindrical constructs in the equine tuber coxae. (c) Histological assessment of new bone (*) within the MgPSr-PCL30 scaffolds after 6 months. Representative haematoxylin and eosin, basic fuchsin/methylene blue-stained MMA samples, immunohistochemical staining for collagen type I (brown region), and picrosirius red–stained tissue sections of defects filled by MgPSr-PCL30 scaffolds (S) and of empty defects. The scale bar is 50 μm. Adapted from.35